{"protocolSection":{"identificationModule":{"nctId":"NCT06160726","orgStudyIdInfo":{"id":"NNS-SOT-01"},"organization":{"fullName":"Nunaps Inc","class":"INDUSTRY"},"briefTitle":"MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke","officialTitle":"Evaluating the Validation of MRI-based Artificial Intelligence Software (NNS-SOT) for Onset Time Estimation in Lesion With Acute Ischemic Stroke : a Single-center, Single-arm, Single-blind (Evaluator), Retrospective Pivotal Trial"},"statusModule":{"statusVerifiedDate":"2023-11","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-10-24","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2023-11-07","type":"ACTUAL"},"completionDateStruct":{"date":"2023-11-07","type":"ACTUAL"},"studyFirstSubmitDate":"2023-11-29","studyFirstSubmitQcDate":"2023-11-29","studyFirstPostDateStruct":{"date":"2023-12-07","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-29","lastUpdatePostDateStruct":{"date":"2023-12-07","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Nunaps Inc","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study evaluates the efficacy of investigational device named Stroke Onset Time Artificial Intelligence(AI) (Model name:NNS-SOT). Using the investigational device, analyze the image and the onset time of occurrence of acute ischemic stroke lesion on the brain image (4.5 hours or more from the onset of symptoms) and evaluate the efficacy of correctly estimating the onset time.","detailedDescription":"This clinical trial software medical device (Model name: NNS-SOT) is developed based on artificial intelligence algorithms.\n\nThrough clinical validation, it will be easier to determine whether the golden hour (4.5 hours) has elapsed at the time of cerebral infarction in the medical field. It can be used for estimation of the onset time of occurrence in acute ischemic stroke."},"conditionsModule":{"conditions":["Acute Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"RETROSPECTIVE"},"enrollmentInfo":{"count":474,"type":"ACTUAL"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Sensitivity and specificity","description":"Evaluation of sensitivity and specificity of clinical performance (estimation of 4.5 hours or more after cerebral infarction) performed with clinical trial medical device","timeFrame":"October - November 2023"}],"secondaryOutcomes":[{"measure":"Area Under the Curve(AUC), which is the lower area of the Receiver Operating Characteristics(ROC) curve","description":"Lower limit of 95% confidence interval is 80% or more","timeFrame":"October - November 2023"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Brain imaging in patients with acute ischemic stroke aged 20 years and older\n* Brain imaging of ischemic stroke manifestation lesion confirmed by medical staff in brain MR image\n* Brain imaging taken within 24 hours of ischemic stroke symptoms\n* Brain imaging including Magnetic Resonance(MR) images (DWI and FLAIR)\n* Patients with clearly recorded onset time of acute ischemic stroke symptoms\n\nExclusion Criteria:\n\n* Brain imaging used in NNS-SOT development process\n* Brain imaging with noise (Artifact)\n* Brain images damaged in data","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Cerebral infarction disease Brain imaging data taken from 474 subjects who visited clinical trial institution (From 2017 to March 27, 2023)","samplingMethod":"PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Bum Joon Kim, MD, PhD","affiliation":"Asan Medical Center","role":"PRINCIPAL_INVESTIGATOR"}],"locations":[{"facility":"Asan Medical Center","city":"Seoul","country":"Korea, Republic of","geoPoint":{"lat":37.566,"lon":126.9784}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000002544","term":"Cerebral Infarction"},{"id":"D000007511","term":"Ischemia"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"},{"id":"D000020520","term":"Brain Infarction"},{"id":"D000002545","term":"Brain Ischemia"},{"id":"D000007238","term":"Infarction"},{"id":"D000009336","term":"Necrosis"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","asFound":"Ischemic","relevance":"HIGH"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M9972","name":"Infarction","relevance":"LOW"},{"id":"M5483","name":"Cerebral Infarction","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M21995","name":"Brain Infarction","relevance":"LOW"},{"id":"M5484","name":"Brain Ischemia","relevance":"LOW"},{"id":"M11974","name":"Necrosis","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}